首页> 外文期刊>Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases >Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC
【24h】

Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC

机译:传感器激酶酰胺缺失突变在缺失突变中介导的丙基霉素抗性机制,导致Exbc的Efflux泵的表达升高

获取原文
获取原文并翻译 | 示例
           

摘要

Acinetobacter baumannii is an important pathogen and presents a major burden in healthcare as strains frequently cause hospital associated opportunistic infections with high mortality rates. Due to increasing numbers of drug resistant A. baumannii strains, newly developed antibiotics are being used to treat infections caused by such strains. One novel synthetic antibiotic of the tetracycline class with activity against A. baumannii is eravacycline. To investigate possible mechanisms of eravacycline resistance, we performed an in vitro evolution experiment to select for an eravacycline resistant strain, with the clinical isolate MDR-ZJ06 as parental strain. We obtained a strain designated MDR-ZJ06-E6 that was able to grow in 64-fold MIC. Genomic mutations were identified by whole genome sequencing, where we found a deletion mutation in the gene adeS. Using complementation experiments, including growth rate determination and antibiotics susceptibility testing, we could confirm that this mutation was responsible for eravacycline resistance of strain MDR-ZJ06-E6. As a mechanism of resistance, we identified a significant overexpression of the efflux pump AdeABC which seems to be regulated by the mutation in adeS in A. baumannii.
机译:AcineTobacter Baumannii是一个重要的病原体,并且在医疗保健中提出了一个主要负担,因为菌株经常导致医院相关的机会主义感染具有高死亡率。由于耐药患者含量越来越多。Baumannii菌株,新开发的抗生素用于治疗这种菌株引起的感染。具有针对A.Baumannii的活性的四环素类的一种新型合成抗生素是厄伐非的。为了研究可能的抗替代素抗性的可能机制,我们进行了一种体外演化实验,以选择抗替代旋流菌株,临床分离型MDR-ZJ06作为父母菌株。我们获得了一个菌株指定的MDR-ZJ06-E6,其能够在64倍的MIC中生长。通过全基因组测序鉴定基因组突变,在那里我们发现基因酰胺中的缺失突变。使用互补实验,包括生长速率测定和抗生素易感性测试,我们可以证实该突变负责菌株MDR-ZJ06-E6的季替氏菌抗性。作为抗性的机制,我们鉴定了Exflux泵的显着过度表达,其似乎受A.Baumannii中的突变的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号